Close
Patheon

News Releases

  • 01 Apr 2015
    Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, has closed the previously announced transaction to acquire IRIX Pharmaceuticals, a Florence, S.C.-headquartered company that specializes in making difficult to manufacture Active Pharmaceutical Ingredients (API) for drugs from early and late development, through commercial launch. With the acquisition, Patheon establishes a North American presence formore...
  • 20 Mar 2015
    Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, has closed the previously announced transaction to acquire Agere Pharmaceuticals, Inc., a privately-held CDMO, that specializes in improving the absorption rate of medications (bioavailability). The company will become part of Patheon’s pharmaceutical development services unit and operate as a solubility center of excellence in Bend, Ore.About PatheonPatheon,more...
  • 12 Mar 2015
    Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sector, will participate at DCAT Week 2015 in New York, March 16-19.Patheon recently announced two acquisitions in support of the company’s business strategy to enter into logical adjacencies and drive industry consolidation. Patheon offerings now include North American API development and manufacturing services with the addition of IRIX Pharmaceuticals and amore...

Media Contact

Mari Mansfield
4815 Emperor Blvd.,
Durham, NC 27703
(919) 226-3137
mari.mansfield@patheon.com

 
 

Media Contact

Mari Mansfield
4815 Emperor Blvd.,
Durham, NC 27703
(919) 226-3137
mari.mansfield@patheon.com